The second tier of Peripheral Guide Wires segmentation is organized by application, reflecting the procedural contexts that drive demand. Peripheral Intervention—including lower‑extremity angioplasty, atherectomy, and stent placement—dominates the landscape, representing approximately 55 % of market volume, a share corroborated by the accompanying pie‑chart. Coronary Intervention leverages peripheral‑grade wires for selected right‑coronary‑artery procedures, accounting for about 25 % of sales, underscoring cross‑specialty utilization. Neurovascular Intervention, wherein guide wires navigate cerebral and spinal vessels, contributes roughly 15 % of the market, a segment expanding alongside minimally invasive neurosurgery. Diagnostic Imaging applications, such as contrast‑enhanced peripheral angiography, remain modest at 5 %, reflecting limited but essential usage for procedural planning. Each application segment translates directly into revenue streams: higher‑complexity interventions demand premium‑priced, performance‑optimized wires, while diagnostic uses rely on cost‑effective, standard‑spec products. The proportional distribution captured in the chartData thus mirrors the clinical intensity and price differentiation across the application spectrum and informs strategic positioning for manufacturers.
